TickerFacts.

Abvc Biopharma, Inc. (ABVC): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2011-09-30, 2023-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$4.21M
Year ended 2023-12-31
2010-09-30: -$1.05M2011-09-30: -$1.62M2012-09-30: -$915.5K2013-09-30: -$37.8K2021-12-31: -$7.62M2022-12-31: -$7.52M2023-12-31: -$4.21M-$4.21M
2010-09-30 Free Cash Flow (USD) 2023-12-31
Period endedFree Cash FlowChange YoYSource filing
2023-12-31-$4.21Mn/c2025-04-15, From 2023-01-01
2022-12-31-$7.52Mn/m2024-03-13, From 2022-01-01
2021-12-31-$7.62Mn/a2023-03-31, From 2021-01-01
No annual figure between 2013-09-30 and 2021-12-31.
2013-09-30-$37.8Kn/m2015-04-16, From 2012-10-01
2012-09-30-$915.5Kn/m2015-04-16, From 2011-10-01
2011-09-30-$1.62Mn/c2015-04-15, From 2010-10-01
2010-09-30-$1.05Mn/a2011-12-28, From 2009-10-01